Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-cash Items (2020 - 2025)

Journey Medical's Non-cash Items history spans 6 years, with the latest figure at $6.4 billion for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items rose 2.7% year-over-year to $6.4 billion, compared with a TTM value of $6.4 billion through Dec 2025, up 2.7%, and an annual FY2025 reading of $6.4 billion, up 2.7% over the prior year.
  • Non-cash Items for Q4 2025 was $6.4 billion at Journey Medical, up from $5.5 million in the prior quarter.
  • The five-year high for Non-cash Items was $9.7 billion in Q4 2021, with the low at $1.6 million in Q1 2023.
  • Average Non-cash Items over 5 years is $1.6 billion, with a median of $9.6 million recorded in 2022.
  • Year-over-year, Non-cash Items soared 121667.12% in 2021 and then crashed 81.83% in 2023.
  • Tracing DERM's Non-cash Items over 5 years: stood at $9.7 billion in 2021, then plummeted by 77.04% to $2.2 billion in 2022, then surged by 55.16% to $3.4 billion in 2023, then skyrocketed by 79.94% to $6.2 billion in 2024, then grew by 2.7% to $6.4 billion in 2025.
  • Per Business Quant, the three most recent readings for DERM's Non-cash Items are $6.4 billion (Q4 2025), $5.5 million (Q3 2025), and $14.7 million (Q2 2025).